Form 4: Neurocrine Biosciences CEO Kyle Gano Acquires Shares and Stock Options
SEC Form 4 Filing
Neurocrine Biosciences CEO Kyle Gano reports acquisition of restricted stock units and stock options.
Summary
- On November 1, 2024, Kyle Gano, CEO of Neurocrine Biosciences, acquired 2,455 restricted stock units and 13,344 stock options.
- The restricted stock units vest annually, with 1/4 vesting on each of November 1, 2025, 2026, 2027, and 2028.
- The stock options vest monthly, with 1/48th of the shares underlying the option becoming vested and exercisable on December 1, 2024, and an additional 1/48th each month thereafter until November 1, 2034.
- Following the transaction, Gano directly owns 2,455 restricted stock units and 13,344 stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction report. The acquisition of shares and options by the CEO is generally viewed as a positive signal, but it's a routine event.
Positives
- The acquisition of stock options and restricted stock units by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting schedules for the restricted stock units and stock options provide incentives for the CEO to drive long-term value for the company.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's prospects. This filing is a routine disclosure of such transactions.
Stakeholder Impact
- The vesting schedules for the restricted stock units and stock options align the CEO's interests with those of the shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 12/01/2024 | First vesting date for stock options (1/48th of shares). |
| 11/01/2025 | First vesting date for restricted stock units (1/4 of units). |
| 11/01/2026 | Second vesting date for restricted stock units (1/4 of units). |
| 11/01/2027 | Third vesting date for restricted stock units (1/4 of units). |
| 11/01/2028 | Final vesting date for restricted stock units (1/4 of units). |
| 11/01/2034 | Expiration date for stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.